P. Richter < P. Riederer < P. Rioux

Facettes :

List of bibliographic references indexed by P. Riederer

Number of relevant bibliographic references: 20.

Ident.	Authors (with country if any)	Title
001C47 (2000)	G. Münch [Allemagne] ; H. J. Lüth [Allemagne] ; A. Wong [Allemagne] ; Th. Arendt [Allemagne] ; E. Hirsch [France] ; R. Ravid [Pays-Bas] ; P. Riederer [Allemagne]	Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation?
002187 (1996)	H. Przuntek ; D. Welzel [Allemagne] ; M. Gerlach ; E. Blümner [Allemagne] ; W. Danielczyk [Autriche] ; -J. Kaiser ; H. Kraus ; H. Letzel [Allemagne] ; P. Riederer ; K. Überla [Allemagne]	Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study
002209 (1996)	M. Gerlach [Allemagne] ; P. Riederer [Allemagne]	Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
002504 (1993)	Youdim [Israël] ; D. Ben-Shachar [Israël] ; P. Riederer [Allemagne]	The possible role of iron in the etiopathology of parkinson's disease
002544 (1993)	J. Kornhuber [Allemagne] ; M. Weller [Allemagne] ; P. Riederer [Allemagne]	Glutamate receptor antagonists for neuroleptic malignant syndrome and akitetic hyperthermic Parkinsonian crisis
002552 (1993)	H. Youdim [Israël] ; P. Riederer [Allemagne]	Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition
002644 (1992)	H. Przuntek [Allemagne] ; D. Welzel [Allemagne] ; E. Blümner [Allemagne] ; W. Danielczyk [Autriche] ; H. Letzel [Allemagne] ; -J. Kaiser [Allemagne] ; H. Kraus [Allemagne] ; P. Riederer [Allemagne] ; D. Schwarzmann [Allemagne] ; H. Wolf [Allemagne] ; K. Überla [Allemagne]	Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued
002787 (1990)	K. Jellinger [Autriche] ; W. Paulus [Autriche] ; I. Grundke-Iqbal [États-Unis] ; P. Riederer [Allemagne] ; H. Youdim [Israël]	Brain iron and ferritin in Parkinson's and Alzheimer's diseases
002833 (1989)	M. B. H. Youdim ; D. Ben-Shachar ; P. Riederer [Allemagne]	Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?
002877 (1988)	E. Sofic [Allemagne] ; P. Riederer [Allemagne] ; H. Heinsen [Allemagne] ; H. Beckmann [Allemagne] ; P. Reynolds [Royaume-Uni] ; G. Hebenstreit [Autriche] ; H. Youdim [Israël]	Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
002A13 (1985)	W. Birkmayer [Autriche] ; J. Knoll [Hongrie] ; P. Riederer [Autriche] ; H. Youdim [Israël] ; Vera Hars [Hongrie] ; J. Marton [Hongrie]	Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study
002A84 (1983)	P. Riederer [Autriche] ; K. Jellinger [Autriche]	Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline)
002B62 (1980)	K. Jellinger ; H. Flament ; P. Riederer ; H. Schmid ; L. Ambrozi	Levodopa in the treatment of (PRE) senile dementia
002B81 (1979)	W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; M. B. H. Youdim [Israël]	Distinction between benign and malignant type of parkinson's disease
002C33 (1977)	P. Riederer [Autriche] ; W. Birkmayer [Autriche] ; D. Seemann [Autriche] ; St. Wuketich [Autriche]	Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome
002C41 (1976)	P. Riederer [Autriche] ; St. Wuketich [Autriche]	Time course of nigrostriatal degeneration in parkinson's disease
002C56 (1975)	W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; H. Youdim [Autriche] ; W. Linauer [Autriche]	The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil
002C69 (1974)	W. Birkmayer [Autriche] ; W. Danielczyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche]	Nucleus ruber and L-Dopa psychosis: Biochemical post-mortem findings
002C83 (1973)	W. Birkmayer [Autriche] ; W. Danielcyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche]	L-dopa level in plasma, primary condition for the kinetic effect
002C95 (1972)	W. Birkmayer [Autriche] ; W. Danielczyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche]	The balance of biogenic amines as condition for normal behaviour

---

List of associated KwdEn.i

Nombre de documents	Descripteur
4	Parkinson's disease
2	Oxidative stress
1	Advanced glycation endproducts
1	Calcium homeostasis
1	Iron
1	Lewy bodies
1	Membrane lipid peroxidation
1	Neurodegeneration
1	Oxygen free radical
1	Substantia nigra zona compacta
1	deprenyl (selegiline)
1	free radicals
1	glia
1	iron
1	melanin
1	monoamine oxidase

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "P. Riederer" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "P. Riederer" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    P. Riederer
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024